I'd like the 4 years and more please

The mTNBC trial includes multiple outcome measures through 2 yrs of observation. https://clinicaltrials.gov/study/NCT03838367 and the date of the news release with preliminary analysis of the 12 month data was July 19, 2021. We haven't yet been told details of the 2 year outcomes. Recently, the February 24, 2025 press release mentions that "Following the resolution of the Company’s dispute with its former CRO, CytoDyn obtained follow-up records from patients treated with leronlimab during the Company’s prior clinical trials in oncology. After confirming these patient outcomes, CytoDyn worked with consultants and key opinion leaders to summarize the findings and submit an abstract to the European Society for Medical Oncology (ESMO) Breast Cancer meeting taking place in Munich, Germany, from May 14 to 17, 2025."

February 24, 2025 press release
https://www.cytodyn.com/newsroom/press-releases/detail/635/cytodyn-announces-promising-survival-observations-in-mtnbc

May 15, 2025 ESMO poster (coming up)
https://cslide.ctimeetingtech.com/breast2025/attendee/confcal/presentation/list?q=leronlimab

The recent news in February 2025 suggests that because of the settlement with the former CRO (which ended up paying CytoDyn and turning over follow-up records to CytoDyn from patients in clinical trials), we will now learn some in May 2025 not only about the 2 year outcome measures from the trial protocol, but we will learn some also about even longer survivability.

These dates below are based on the preliminary 12 month observation press release on July 19, 2021 and they approximate the dates marking years of survivability. Considering that we've been told in February 2025 that some patients are still alive, it seems to appear that some of the patients have been confirmed to have survived more than 4 years.

2021.07.19 year 1 observation results press release
2022.07.19 year 2
2023.07.19 year 3
2024.07.19 year 4